Wabash National Corporation Announces Earnings Release Date
Apr 05, 2017 20:30 pm UTC| Business
LAFAYETTE, Ind., April 05, 2017 -- Wabash National Corporation (NYSE:WNC) today announced it will conduct a conference call to review and discuss its first quarter results on Tuesday, April 25, 2017, at 10:00 a.m. EDT....
Apr 05, 2017 20:30 pm UTC| Business
BOSTON, April 05, 2017 -- Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ:GECC), today announced that today it is commencing its previously announced modified “Dutch auction” tender offer to purchase for cash...
Xtant™ Medical Receives Going Concern Opinion
Apr 05, 2017 20:25 pm UTC| Business
BELGRADE, Mont., April 05, 2017 -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that as previously disclosed in its...
Peak Resorts Declares Quarterly Cash Dividend Payment
Apr 05, 2017 20:15 pm UTC| Business
WILDWOOD, Mo., April 05, 2017 -- Peak Resorts, Inc. (NASDAQ:SKIS), a leading owner and operator of high-quality, individually branded ski resorts, today announced that its Board of Directors approved a quarterly cash...
Pzena Investment Management, Inc. Announces First-Quarter 2017 Earnings Conference Call
Apr 05, 2017 20:15 pm UTC| Business
NEW YORK, April 05, 2017 -- Pzena Investment Management, Inc. (NYSE:PZN) today announced that it will hold a conference call to discuss the Company’s financial results and outlook at 10:00 a.m. ET, Wednesday, April 19,...
Whole Foods Market Announces Second Quarter Earnings Conference Call and Webcast
Apr 05, 2017 20:15 pm UTC| Business
AUSTIN, Texas, April 05, 2017 -- Whole Foods Market (NASDAQ:WFM) today announced it will issue financial results for the Company’s second fiscal quarter ending April 9, 2017, after the market closes on Wednesday, May...
Apr 05, 2017 20:13 pm UTC| Business
WALTHAM, Mass., April 05, 2017 -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases...